These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34689082)

  • 1. Discovery of novel ibrutinib analogues to treat malignant melanoma.
    Ren S; Wang X; Song J; Jin G
    Bioorg Chem; 2021 Dec; 117():105419. PubMed ID: 34689082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel 4(1H)-quinolone derivatives as potential antiproliferative and apoptosis inducing agents.
    Zhou P; Huang L; Zhou J; Jiang B; Zhao Y; Deng X; Zhao Q; Li F
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4185-4189. PubMed ID: 28757067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and structure-activity relationship of novel diphenylthiazole derivatives as BTK inhibitor with potent activity against B cell lymphoma cell lines.
    Guo X; Yang D; Fan Z; Zhang N; Zhao B; Huang C; Wang F; Ma R; Meng M; Deng Y
    Eur J Med Chem; 2019 Sep; 178():767-781. PubMed ID: 31234030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfonylguanidine Derivatives as Potential Antimelanoma Agents.
    Baladi T; Hamouda-Tekaya N; Gonçalves LCP; Rocchi S; Ronco C; Benhida R
    ChemMedChem; 2020 Jul; 15(13):1113-1117. PubMed ID: 32347004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugate of ibrutinib with a TLR7 agonist suppresses melanoma progression and enhances antitumor immunity.
    Ren S; Wang X; Jin G
    Int J Biol Sci; 2022; 18(1):166-179. PubMed ID: 34975325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-Activity Relationships within a Series of σ
    Franchini S; Sorbi C; Battisti UM; Tait A; Bencheva LI; Cichero E; Fossa P; Cilia A; Prezzavento O; Ronsisvalle S; Aricò G; Benassi L; Vaschieri C; Azzoni P; Magnoni C; Brasili L
    ChemMedChem; 2017 Nov; 12(22):1893-1905. PubMed ID: 28940806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDKN1C-mediated growth inhibition by an EZH1/2 dual inhibitor overcomes resistance of mantle cell lymphoma to ibrutinib.
    Kagiyama Y; Fujita S; Shima Y; Yamagata K; Katsumoto T; Nakagawa M; Honma D; Adachi N; Araki K; Kato A; Inaki K; Ono Y; Fukuhara S; Kobayashi Y; Tobinai K; Kitabayashi I
    Cancer Sci; 2021 Jun; 112(6):2314-2324. PubMed ID: 33792119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of aloperine derivatives as potential anticancer agents.
    Zhao TT; Shen LY; Cheng Y; Liu XY; Chen K; Sun BM; Li Y; Pan XD
    J Asian Nat Prod Res; 2024 Sep; 26(9):1057-1086. PubMed ID: 38920368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chinese Propolis Exerts Anti-Proliferation Effects in Human Melanoma Cells by Targeting NLRP1 Inflammatory Pathway, Inducing Apoptosis, Cell Cycle Arrest, and Autophagy.
    Zheng Y; Wu Y; Chen X; Jiang X; Wang K; Hu F
    Nutrients; 2018 Aug; 10(9):. PubMed ID: 30149677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin Inhibits Proliferation and Induces Apoptosis of B16 Melanoma Cells
    Soll F; Ternent C; Berry IM; Kumari D; Moore TC
    Assay Drug Dev Technol; 2020; 18(6):261-268. PubMed ID: 32799543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebivolol, an antihypertensive agent, has new application in inhibiting melanoma.
    Yang S; Li Z; Yi J; Pan M; Cao W; Ma J; Zhang P
    Anticancer Drugs; 2024 Jul; 35(6):512-524. PubMed ID: 38602174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug repurposing: Discovery of troxipide analogs as potent antitumor agents.
    Lu N; Huo JL; Wang S; Yuan XH; Liu HM
    Eur J Med Chem; 2020 Sep; 202():112471. PubMed ID: 32619887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the IL-2 inducible kinase in melanoma; a phase 2 study of ibrutinib in systemic treatment-refractory distant metastatic cutaneous melanoma: preclinical rationale, biology, and clinical activity (NCI9922).
    Moschos SJ; Eroglu Z; Khushalani NI; Kendra KL; Ansstas G; In GK; Wang P; Liu G; Collichio FA; Googe PB; Carson CC; McKinnon K; Wang HH; Nikolaishvilli-Feinberg N; Ivanova A; Arrowood CC; Garrett-Mead N; Conway KC; Edmiston SN; Ollila DW; Serody JS; Thomas NE; Ivy SP; Agrawal L; Dees EC; Abbruzzese JL
    Melanoma Res; 2021 Apr; 31(2):162-172. PubMed ID: 33661190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug repurposing and rediscovery: Design, synthesis and preliminary biological evaluation of 1-arylamino-3-aryloxypropan-2-ols as anti-melanoma agents.
    Chang Q; Long J; Hu L; Chen Z; Li Q; Hu G
    Bioorg Med Chem; 2020 May; 28(9):115404. PubMed ID: 32216987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-((1-Phenyl-1H-1,2,3-triazol-4-yl)methyl)-2-azabicyclo[3.2.1]octan-3-one derivatives: Simplification and modification of aconitine scaffold for the discovery of novel anticancer agents.
    Zhang Y; Zhang TJ; Li XY; Liang JW; Tu S; Xu HL; Xue WH; Qian XH; Zhang ZH; Zhang X; Meng FH
    Eur J Med Chem; 2021 Jan; 210():112988. PubMed ID: 33189438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of 3-functionalized 2-phenyl- and 2-alkylbenzo[b]furans as antiproliferative agents against human melanoma cell line.
    Kwiecień H; Perużyńska M; Stachowicz K; Piotrowska K; Bujak J; Kopytko P; Droździk M
    Bioorg Chem; 2019 Jul; 88():102930. PubMed ID: 31039469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and molecular mechanisms of novel dual inhibitors of heat shock protein 90/phosphoinositide 3-kinase alpha (Hsp90/PI3Kα) against cutaneous melanoma.
    Qin F; Wang Y; Jiang X; Wang Y; Zhang N; Wen X; Wang L; Jiang Q; He G
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):909-926. PubMed ID: 30957641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of the anticancer activity of albiziabioside A and its analogues as apoptosis inducers against human melanoma cells.
    Wei G; Wang S; Cui S; Guo J; Liu Y; Liu Y; Cheng M
    Org Biomol Chem; 2014 Aug; 12(31):5928-35. PubMed ID: 24985523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular diversity of phenothiazines: design and synthesis of phenothiazine-dithiocarbamate hybrids as potential cell cycle blockers.
    Fu DJ; Zhao RH; Li JH; Yang JJ; Mao RW; Wu BW; Li P; Zi XL; Zhang QQ; Cai HJ; Zhang SY; Zhang YB; Liu HM
    Mol Divers; 2017 Nov; 21(4):933-942. PubMed ID: 28785928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionalized Caprolactone-Polyethylene Glycol Based Thermo-Responsive Hydrogels of Silibinin for the Treatment of Malignant Melanoma.
    Makhmalzadeh BS; Molavi O; Vakili MR; Zhang HF; Solimani A; Abyaneh HS; Loebenberg R; Lai R; Lavasanifar A
    J Pharm Pharm Sci; 2018; 21(1):143-159. PubMed ID: 29789104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.